Cervical cancer is the fourth most frequent cancer in women worldwide,representing 6.6 percent of all female-related cancers,according to the World Health Organization(WTO).An estimated 570,000 new cases of cervical c...Cervical cancer is the fourth most frequent cancer in women worldwide,representing 6.6 percent of all female-related cancers,according to the World Health Organization(WTO).An estimated 570,000 new cases of cervical cancer were reported worldwide in 2018.The development o f AI(artificial intelligence)has helped improve medical treatments.In fact,a research team,led by Sun Xiaorong,Chairperson of Wuhan Landing Medical High-tech Co.,Ltd.,has established the automated,intelligent and standardized Landing cyto-scanning mechanism,to provide diagnoses of cervical cancer.By applying cutting-edge AI and cloud technologies,Sunfs team has helped reduce the global mortality rate(from the cancer)of women.展开更多
Three-dimensional(3D) printing technology has been widely used in various manufacturing operations including automotive, defence and space industries. 3D printing has the advantages of personalization, flexibility and...Three-dimensional(3D) printing technology has been widely used in various manufacturing operations including automotive, defence and space industries. 3D printing has the advantages of personalization, flexibility and high resolution, and is therefore becoming increasingly visible in the high-tech fields. Three-dimensional bio-printing technology also holds promise for future use in medical applications. At present 3D bio-printing is mainly used for simulating and reconstructing some hard tissues or for preparing drug-delivery systems in the medical area. The fabrication of 3D structures with living cells and bioactive moieties spatially distributed throughout will be realisable. Fabrication of complex tissues and organs is still at the exploratory stage. This review summarize the development of 3D bio-printing and its potential in medical applications, as well as discussing the current challenges faced by 3D bio-printing.展开更多
文摘Cervical cancer is the fourth most frequent cancer in women worldwide,representing 6.6 percent of all female-related cancers,according to the World Health Organization(WTO).An estimated 570,000 new cases of cervical cancer were reported worldwide in 2018.The development o f AI(artificial intelligence)has helped improve medical treatments.In fact,a research team,led by Sun Xiaorong,Chairperson of Wuhan Landing Medical High-tech Co.,Ltd.,has established the automated,intelligent and standardized Landing cyto-scanning mechanism,to provide diagnoses of cervical cancer.By applying cutting-edge AI and cloud technologies,Sunfs team has helped reduce the global mortality rate(from the cancer)of women.
基金supported by the National Basic Research Program of China(2011CB965000)Chinese Academy of Sciences Strategic Priority Research Program Grants(XDA01030506)
文摘Three-dimensional(3D) printing technology has been widely used in various manufacturing operations including automotive, defence and space industries. 3D printing has the advantages of personalization, flexibility and high resolution, and is therefore becoming increasingly visible in the high-tech fields. Three-dimensional bio-printing technology also holds promise for future use in medical applications. At present 3D bio-printing is mainly used for simulating and reconstructing some hard tissues or for preparing drug-delivery systems in the medical area. The fabrication of 3D structures with living cells and bioactive moieties spatially distributed throughout will be realisable. Fabrication of complex tissues and organs is still at the exploratory stage. This review summarize the development of 3D bio-printing and its potential in medical applications, as well as discussing the current challenges faced by 3D bio-printing.
